DK62692D0 - - Google Patents
Info
- Publication number
- DK62692D0 DK62692D0 DK92626A DK62692A DK62692D0 DK 62692 D0 DK62692 D0 DK 62692D0 DK 92626 A DK92626 A DK 92626A DK 62692 A DK62692 A DK 62692A DK 62692 D0 DK62692 D0 DK 62692D0
- Authority
- DK
- Denmark
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK92626A DK62692D0 (hr) | 1992-05-14 | 1992-05-14 | |
IL105673A IL105673A (en) | 1992-05-14 | 1993-05-11 | Use of n-substituted adenosine derivatives for the preparation of medicaments for treating myocardial or cerebral ischemia, certain novel n-substituted adenosine derivatives and pharmaceutical compositions containing them |
JP5519787A JPH06508855A (ja) | 1992-05-14 | 1993-05-12 | プリン誘導体 |
NZ252110A NZ252110A (en) | 1992-05-14 | 1993-05-12 | Adenosine derivatives and pharmaceutical compositions |
AU40612/93A AU671995B2 (en) | 1992-05-14 | 1993-05-12 | Purine derivatives |
EP93909822A EP0603348A1 (en) | 1992-05-14 | 1993-05-12 | Purine derivatives |
PCT/DK1993/000158 WO1993023418A1 (en) | 1992-05-14 | 1993-05-12 | Purine derivatives |
CA002113547A CA2113547A1 (en) | 1992-05-14 | 1993-05-12 | Purine derivatives |
FI940167A FI940167A (fi) | 1992-05-14 | 1994-01-13 | Puriinijohdannaisia |
NO940123A NO940123L (no) | 1992-05-14 | 1994-01-13 | Purinderivater |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK92626A DK62692D0 (hr) | 1992-05-14 | 1992-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK62692D0 true DK62692D0 (hr) | 1992-05-14 |
Family
ID=8095717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92626A DK62692D0 (hr) | 1992-05-14 | 1992-05-14 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0603348A1 (hr) |
JP (1) | JPH06508855A (hr) |
AU (1) | AU671995B2 (hr) |
CA (1) | CA2113547A1 (hr) |
DK (1) | DK62692D0 (hr) |
FI (1) | FI940167A (hr) |
IL (1) | IL105673A (hr) |
NZ (1) | NZ252110A (hr) |
WO (1) | WO1993023418A1 (hr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK155292D0 (da) * | 1992-12-23 | 1992-12-23 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
BR9507683A (pt) * | 1994-05-10 | 1997-09-23 | Sandoz Ag | Derivados de adenosina |
EP0704215A3 (en) * | 1994-06-02 | 1998-04-01 | Takeda Chemical Industries, Ltd. | Inhibitor of vascular permeability enhancer |
GB9421133D0 (en) * | 1994-10-20 | 1994-12-07 | Glaxo Group Ltd | Medicaments |
US6110902A (en) * | 1997-06-23 | 2000-08-29 | Moehler; Hanns | Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine |
US6803457B1 (en) | 1999-09-30 | 2004-10-12 | Pfizer, Inc. | Compounds for the treatment of ischemia |
CO5180581A1 (es) * | 1999-09-30 | 2002-07-30 | Pfizer Prod Inc | Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia |
WO2001087843A1 (en) * | 2000-05-15 | 2001-11-22 | Novo Nordisk A/S | Compounds for treating disorders where a decreased level of plasma ffa is desired |
US7414036B2 (en) | 2002-01-25 | 2008-08-19 | Muscagen Limited | Compounds useful as A3 adenosine receptor agonists |
US20100048501A1 (en) | 2006-03-21 | 2010-02-25 | Heinrich-Heine-Universitat Dusseldorf | Phosphorylated A2A Receptor Agonists |
CZ2009298A3 (cs) * | 2009-05-14 | 2010-11-24 | Univerzita Palackého v Olomouci | Substituované 6-benzylaminopurin ribosidy, jejich použití a farmaceutický prípravek tyto slouceniny obsahující |
EP2523669B1 (en) | 2010-01-11 | 2016-12-07 | Inotek Pharmaceuticals Corporation | Combination, kit and method of reducing intraocular pressure |
MX2012010724A (es) | 2010-03-26 | 2012-11-12 | Inotek Pharmaceuticals Corp | Metodo para reducir la presion intraocular en seres humanos empleando n6-ciclopentiladenosina (cpa), derivados de cpa o profarmacos de los mismos. |
KR20130029049A (ko) | 2010-03-26 | 2013-03-21 | 이노텍 파마슈티컬스 코포레이션 | 아데노신 화합물 및 이의 용도 |
NZ627778A (en) | 2012-01-26 | 2017-01-27 | Inotek Pharmaceuticals Corp | Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof |
SG11201506882YA (en) | 2013-03-15 | 2015-09-29 | Inotek Pharmaceuticals Corp | Ophthalmic formulations |
JP2015172077A (ja) * | 2015-06-24 | 2015-10-01 | 中国医学科学院葯物研究所 | N6−置換アデノシン誘導体とn6−置換アデニン誘導体の鎮静、催眠、抗うつ、抗痙攣、抗てんかん、抗パーキンソン病と認知証予防・治療の用途 |
GB2582361A (en) * | 2019-03-21 | 2020-09-23 | Univ Warwick | Adenosine receptor agonists |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL128629C (hr) * | 1966-05-07 | |||
DE1670077C3 (de) * | 1966-05-07 | 1975-04-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Adenosin-Derivate und Verfahren zu ihrer Herstellung |
NL6717061A (hr) * | 1966-12-21 | 1968-06-24 | ||
DE2052596A1 (de) * | 1970-10-27 | 1972-05-04 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten |
DE3406533A1 (de) * | 1984-02-23 | 1985-08-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten |
JPH0655756B2 (ja) * | 1984-04-18 | 1994-07-27 | ネルソン・リサ−チ・アンド・デベロツプメント・カンパニ− | 心臓血管拡張薬としてのn−6置換アデノシン誘導体 |
US4791103A (en) * | 1985-02-08 | 1988-12-13 | Warner-Lambert Company | 2,N6 -disubstituted adenosines, derivatives and methods of use |
JPH0696534B2 (ja) * | 1986-04-25 | 1994-11-30 | ヘキストジヤパン株式会社 | 抗痴呆剤 |
GB8729994D0 (en) * | 1987-12-23 | 1988-02-03 | Glaxo Group Ltd | Chemical compounds |
HUT61567A (en) * | 1990-12-07 | 1993-01-28 | Sandoz Ag | Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate |
DK62592D0 (hr) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As |
-
1992
- 1992-05-14 DK DK92626A patent/DK62692D0/da unknown
-
1993
- 1993-05-11 IL IL105673A patent/IL105673A/en not_active IP Right Cessation
- 1993-05-12 WO PCT/DK1993/000158 patent/WO1993023418A1/en not_active Application Discontinuation
- 1993-05-12 CA CA002113547A patent/CA2113547A1/en not_active Abandoned
- 1993-05-12 JP JP5519787A patent/JPH06508855A/ja active Pending
- 1993-05-12 EP EP93909822A patent/EP0603348A1/en not_active Withdrawn
- 1993-05-12 NZ NZ252110A patent/NZ252110A/en unknown
- 1993-05-12 AU AU40612/93A patent/AU671995B2/en not_active Ceased
-
1994
- 1994-01-13 FI FI940167A patent/FI940167A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4061293A (en) | 1993-12-13 |
AU671995B2 (en) | 1996-09-19 |
JPH06508855A (ja) | 1994-10-06 |
EP0603348A1 (en) | 1994-06-29 |
WO1993023418A1 (en) | 1993-11-25 |
CA2113547A1 (en) | 1993-11-25 |
NZ252110A (en) | 1996-07-26 |
IL105673A0 (en) | 1993-09-22 |
FI940167A (fi) | 1994-03-03 |
FI940167A0 (fi) | 1994-01-13 |
IL105673A (en) | 1998-01-04 |